Da Jan Yang
Directeur Général chez ASCENTAGE PHARMA GROUP INTERNATIONAL
Postes actifs de Da Jan Yang
Sociétés | Poste | Début | Fin |
---|---|---|---|
ASCENTAGE PHARMA GROUP INTERNATIONAL | Directeur Général | 01/05/2009 | - |
Président | 01/05/2009 | - | |
Fondateur | 01/05/2009 | - | |
President | 01/05/2009 | - | |
Ascentage Pharma Group Corp. Ltd.
Ascentage Pharma Group Corp. Ltd. Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Ascentage Pharma Group Corp. Ltd. is a Chinese biopharmaceutical company. The company is based in Hong Kong, Hong Kong. The company was founded by Shao Meng Wang. | Directeur/Membre du Conseil | - | - |
Ascentage International Ltd. | Directeur/Membre du Conseil | - | - |
Shanghai Yasheng Pharmaceutical Technology Co., Ltd. | Directeur/Membre du Conseil | - | - |
Ascentage Pharma Group, Inc. | Directeur/Membre du Conseil | - | - |
Jiangsu Ascentage Pharma Pty Ltd. | Directeur/Membre du Conseil | - | - |
Ascentage Pharma Suzhou Co Ltd
Ascentage Pharma Suzhou Co Ltd Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Suzhou Ascentage Pharma Co., Ltd. is a pharmaceutical company. Suzhou Ascentage Pharma Co., Ltd. is based in Suzhou, China. The Chinese company was founded in 2016 by Guang Feng Wang. The CEO is Da Jan Yang. | Directeur Général | - | - |
Président | - | - |
Historique de carrière de Da Jan Yang
Anciens postes connus de Da Jan Yang
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ascenta Therapeutics, Inc. (California) | Directeur/Membre du Conseil | 01/01/2005 | 01/01/2008 |
Directeur Général | 01/01/2005 | 01/01/2008 | |
Directeur Technique/Scientifique/R&D | 01/01/2004 | 01/01/2008 | |
Fondateur | 01/01/2004 | 01/01/2008 | |
Sun Yat-Sen University | Directeur/Membre du Conseil | 01/09/2003 | 01/09/2006 |
Corporate Officer/Principal | 01/09/2003 | 01/09/2006 | |
░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Da Jan Yang
Sun Yat-Sen University | Undergraduate Degree |
Michigan State University | Doctorate Degree |
Statistiques
Internationale
Chine | 5 |
Etats-Unis | 5 |
Hong Kong | 3 |
Opérationnelle
Director/Board Member | 7 |
Chief Executive Officer | 3 |
Chairman | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ASCENTAGE PHARMA GROUP INTERNATIONAL | Health Technology |
Entreprise privées | 9 |
---|---|
Ascentage Pharma Group Corp. Ltd.
Ascentage Pharma Group Corp. Ltd. Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Ascentage Pharma Group Corp. Ltd. is a Chinese biopharmaceutical company. The company is based in Hong Kong, Hong Kong. The company was founded by Shao Meng Wang. | Health Technology |
Ascentage International Ltd. | |
Shanghai Yasheng Pharmaceutical Technology Co., Ltd. | |
Ascentage Pharma Group, Inc. | |
Jiangsu Ascentage Pharma Pty Ltd. | |
Ascenta Therapeutics, Inc. (California) | |
S*BIO Pte Ltd.
S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Health Technology |
The Chinese Biopharmaceutical Association | |
Ascentage Pharma Suzhou Co Ltd
Ascentage Pharma Suzhou Co Ltd Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Suzhou Ascentage Pharma Co., Ltd. is a pharmaceutical company. Suzhou Ascentage Pharma Co., Ltd. is based in Suzhou, China. The Chinese company was founded in 2016 by Guang Feng Wang. The CEO is Da Jan Yang. | Health Technology |
- Bourse
- Insiders
- Da Jan Yang
- Expérience